PART 2: LONG-ACTING BETA AGONISTS

Course overview

1. Identify results of a randomized, double-blind, placebo-controlled, observational study. 2. Recognize the 2010 Federal Drug Administration (FDA) recommendations for long-acting beta agonists. 3. Indicate safe clinical uses of long-acting beta agonists in combination with inhaled corticosteroids.